May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Benefit of olaparib maintenance in 140 patients with ovarian cancer – ESMO Open
Apr 6, 2025, 14:19

Benefit of olaparib maintenance in 140 patients with ovarian cancer – ESMO Open

ESMO Open shared a post on X about a recent paper by Claudia Marchetti et al. published in ESMO Open:

“Benefit of olaparib maintenance in 140 patients with ovarian cancer, by BRCA mutation type and site. BRCA1-mutated patients in the RING or BRCT and BRCA2-mutated in the RAD51-BD appear to have the greatest benefit from adjuvant olaparib.”

Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study

Authors: Claudia Marchetti et al.

Benefit of olaparib maintenance

Explore more insights and listen to podcast on Ovarian Cancer on OncoDaily.

Benefit of olaparib maintenance

Benefit of olaparib maintenance